Conversion Labs (OTCMKTS:CVLBD) Shares Up 5%

Conversion Labs, Inc. (OTCMKTS:CVLBDGet Rating)’s share price traded up 5% during mid-day trading on Tuesday . The stock traded as high as $1.71 and last traded at $1.69. 44,796 shares were traded during trading, a decline of 44% from the average session volume of 80,256 shares. The stock had previously closed at $1.61.

Conversion Labs Price Performance

The company has a market capitalization of $27.94 million, a PE ratio of -2.41 and a beta of 1.21. The business’s 50 day simple moving average is $1.57 and its 200 day simple moving average is $1.92.

Conversion Labs Company Profile

(Get Rating)

Conversion Labs, Inc engages in the manufacturing, distribution, and sale of natural immune support products containing proprietary yeast beta glucans. Its products are oral intake tablets and topical creams, and gels for skin application. It operates through the Finished Cosmetic Products and Nutraceutical and Cosmetic Additives segments.

Featured Stories

Receive News & Ratings for Conversion Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Conversion Labs and related companies with's FREE daily email newsletter.